• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of urinary assessment scores in the nursing management of patients receiving prostate brachytherapy.

作者信息

Abel L J, Blatt H J, Stipetich R L, Fuscardo J A, Dafoe-Lambie J C, Dorsey A T, Butler W M, Merrick G S

出版信息

Clin J Oncol Nurs. 2000 May-Jun;4(3):126-9.

PMID:11235250
Abstract

Nearly all patients experience some degree of urinary irritative or obstructive symptoms following brachytherapy for definitive treatment of early-stage prostate cancer. The American Urological Association (AUA) Symptom Index is a tool developed to measure urinary function and can be incorporated into postoperative nursing management. When this questionnaire is administered at regular intervals following surgery, the patient's urinary status can be assessed quickly and treatment changes made according to symptoms, with resultant improvement in comfort levels. The postoperative use of the AUA index is recommended for all nurses who care for patients undergoing prostate brachytherapy.

摘要

相似文献

1
The role of urinary assessment scores in the nursing management of patients receiving prostate brachytherapy.
Clin J Oncol Nurs. 2000 May-Jun;4(3):126-9.
2
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.125I前列腺近距离放射治疗后患者报告的长期泌尿发病率及相关生活质量变化的前瞻性评估
Brachytherapy. 2003;2(1):32-9. doi: 10.1016/S1538-4721(03)00012-6.
3
Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.近距离放射治疗后经尿道前列腺切除术后的泌尿系统发病率及尿失禁情况
J Urol. 2005 Mar;173(3):808-12. doi: 10.1097/01.ju.0000152698.20487.0e.
4
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.接受前列腺癌125I近距离放射治疗的患者预防性使用坦索罗辛(哈乐):一项双盲安慰剂对照随机研究的最终报告
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):164-9. doi: 10.1016/j.ijrobp.2004.09.036.
5
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.永久性前列腺近距离放射治疗后的泌尿系统副作用及并发症:MD安德森癌症中心的经验
Urology. 2009 Sep;74(3):601-5. doi: 10.1016/j.urology.2009.04.060. Epub 2009 Jul 8.
6
High-dose brachytherapy for treating prostate cancer: nursing considerations.高剂量近距离放射疗法治疗前列腺癌:护理注意事项
Urol Nurs. 2004 Feb;24(1):39-44, 52.
7
Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.前列腺光选择性激光汽化术后刺激性排尿症状的可预测性
Can J Urol. 2007 Oct;14(5):3710-4.
8
The impact of prostate size on urinary quality of life indexes following laparoscopic radical prostatectomy.腹腔镜前列腺癌根治术后前列腺大小对尿生活质量指标的影响。
J Urol. 2008 May;179(5):1818-22. doi: 10.1016/j.juro.2008.01.050. Epub 2008 Mar 18.
9
PSA spike after brachytherapy For localized prostate cancer.
Urol Nurs. 2007 Dec;27(6):507-10, 518; quiz 511.
10
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.高剂量率(HDR)近距离放射治疗联合低分割外照射放疗治疗局限性前列腺癌后的急性泌尿生殖系统毒性:HDR近距离放射治疗中尿道剂量与急性泌尿生殖系统毒性严重程度之间的相关性
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71. doi: 10.1016/j.ijrobp.2004.11.041.

引用本文的文献

1
Side effects of prostate cancer therapies and potential management.前列腺癌治疗的副作用及潜在管理方法。
J Biol Methods. 2024 Aug 22;11(3):e99010018. doi: 10.14440/jbm.2024.0019. eCollection 2024.